Delivery Order SPE2DB24D1205-SPE2DB25FCZAZ
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,960.42 to AmerisourceBergen Drug Corp for DARZALEX FASPRO 1,800mg-30,000 15ml pharmaceutical product. This firm fixed price, non-set-aside contract was awarded on August 12, 2025, with an ultimate completion date of September 3, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a $35,881.26 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical product, with performance completion targeted for September 9, 2025. This non-competitive delivery order employs firm fixed price pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through...
- The Defense Logistics Agency has awarded a delivery order valued at $23,920.84 to AmerisourceBergen Drug Corp for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty pharmaceutical product. This firm fixed-price delivery order, issued on August 26, 2025, with an ultimate completion date of September 17, 2025, represents a non-competitive award and is performed at the vendor's location in Conshohocken, Pennsylvania. The contract is a child order under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a $119,604.20 delivery order to AmerisourceBergen Drug Corp for DARZALEX FASPRO 1,800MG-30,000 15ML pharmaceutical products, with an ultimate completion date of August 27, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price pricing and designates Conshohocken, Pennsylvania as the place of performance, which serves as AmerisourceBergen's corporate headquarters. The delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $119,604.20 to AmerisourceBergen Drug Corp for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialized pharmaceutical product. This firm fixed-price delivery order, issued on September 9, 2025, with an ultimate completion date of September 30, 2025, was competitively awarded with no set-aside designation. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $11,960.42 firm fixed price delivery order for DARZALEX FASPRO 1,800MG-30,000 15ML, with an ultimate completion date of July 8, 2025. This competitively awarded contract, which carries no set-aside designation, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a $107,643.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for DARZALEX FASPRO 1,800MG-30,000 15ML pharmaceutical product, with an ultimate completion date of August 22, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery location is AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $47,841.68 to AmerisourceBergen Drug Corp for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty pharmaceutical product. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 8, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $123,315.90 for DARZALEX FASPRO 1,800MG-30,000 15ML pharmaceutical product on September 19, 2025, with an ultimate completion date of October 10, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $89,703.15 firm fixed price delivery order to AmerisourceBergen Drug Corp for DARZALEX FASPRO 1,800MG-30,000 15ML, a specialized pharmaceutical product. The contract is unclassified as a set-aside and has an ultimate completion date of September 24, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCZAZDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $35,881.26 to AmerisourceBergen Drug Corp for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML pharmaceutical product. This firm fixed-price delivery order, issued on July 30, 2025, with an ultimate completion date of August 20, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery will be performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was used for this award, indicating it was competitively awarded through open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. Under its prime IDC vehicle with DLA, the company supplies a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare systems worldwide. The current delivery order for DARZALEX FASPRO exemplifies AmerisourceBergen's ongoing role in fulfilling specialized pharmaceutical requirements for the Department of Defense's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $35.9k | 7/30/25 |